Sage Journals: Discover world-class research

Abstract

Pulmonary arterial smooth muscle cell (PASMC) phenotype switching, which is characterized by changes in smooth muscle (SM)-specific gene expression, contributes to vascular remodeling in pulmonary hypertension. In addition, it has been shown that the transcription of SM-specific genes is modulated by cytoskeleton rearrangement. However, the intracellular mechanisms and signaling pathways that regulate these relationships are largely unknown. In the present study, we aimed to investigate the roles that phosphoinositide 3-kinase (PI3K) and protein kinase B (PKB), also known as AKT, play in modulating the cytoskeleton and phenotype of rat PASMCs. To observe the downstream effects of inhibiting or enhancing PI3K/AKT pathway activity, we used various approaches to manipulate protein function and gene expression. Treatment of PASMCs with platelet-derived growth factor (PDGF)-BB or PIK3CA-adenovirus induced cytoskeleton rearrangements and downregulated SM22α and α-SM actin gene expression. Inhibition of PI3K led to blocking of AKT phosphorylation and attenuated the PDGF-BB-induced downregulation of F-actin and SM-specific genes, the downstream effector of PI3K. The decrease in SM22α and α-SM actin mRNA levels induced by PDGF-BB was markedly and reproducibly blocked by LY294002. PI3K/AKT pathway plays a vital role in the modulation of PASMCs cytoskeleton rearrangement and phenotype switching.

Get full access to this article

View all access options for this article.

References

Aspenstrom

(1999). The Rho GTPases have multiple effects on the actin cytoskeleton. Exp Cell Res, 246, 20–25.

Bochaton-Piallat

M.L.

, and Gabbiani

(2005). Modulation of smooth muscle cell proliferation and migration: role of smooth muscle cell heterogeneity. Handb Exp Pharmacol, 170, 645–663.

Carpenter

C.L.

(2000). Actin cytoskeleton and cell signaling. Crit Care Med, 28, N94–N99.

Choi

K.H.

, Kim

J.E.

, Song

N.R.

, Son

J.E.

, Hwang

M.K.

, et al. (2010). Phosphoinositide 3-kinase is a novel target of piceatannol for inhibiting PDGF-BB-induced proliferation and migration in human aortic smooth muscle cells. Cardiovasc Res, 85, 836–844.

, Liu

H.W.

, Forsythe

S.M.

, Kogut

, McConville

J.F.

, et al. (2000). Mutagenesis analysis of human SM22: characterization of actin binding. J Appl Physiol, 89, 1985–1990.

Goncharova

E.A.

, Ammit

A.J.

, Irani

, Carroll

R.G.

, Eszterhas

A.J.

, et al. (2002). PI3K is required for proliferation and migration of human pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol, 283, L354–L363.

Han

, Dong

L.H.

, Zheng

, Shi

J.H.

, Wen

J.K.

, et al. (2009). Smooth muscle 22 alpha maintains the differentiated phenotype of vascular smooth muscle cells by inducing filamentous actin bundling. Life Sci, 84, 394–401.

Hellstrand

, and Albinsson

(2005). Stretch-dependent growth and differentiation in vascular smooth muscle: role of the actin cytoskeleton. Can J Physiol Pharmacol, 83, 869–875.

Humbert

, Morrell

N.W.

, Archer

S.L.

, Stenmark

K.R.

, MacLean

M.R.

, et al. (2004). Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol, 43, 13S–24S.

10.

Jeffery

T.K.

, and Morrell

N.W.

(2002). Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension. Prog Cardiovasc Dis, 45, 173–202.

11.

Kaplan-Albuquerque

, Garat

, Desseva

, Jones

P.L.

, and Nemenoff

R.A.

(2003). Platelet-derived growth factor-BB-mediated activation of Akt suppresses smooth muscle-specific gene expression through inhibition of mitogen-activated protein kinase and redistribution of serum response factor. J Biol Chem, 278, 39830–39838.

12.

Katso

, Okkenhaug

, Ahmadi

, White

, Timms

, et al. (2001). Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Annu Rev Cell Dev Biol, 17, 615–675.

13.

Liu

H.W.

, Halayko

A.J.

, Fernandes

D.J.

, Harmon

G.S.

, McCauley

J.A.

, et al. (2003). The RhoA/Rho kinase pathway regulates nuclear localization of serum response factor. Am J Respir Cell Mol Biol, 29, 39–47.

14.

Mack

C.P.

, and Owens

G.K.

(1999). Regulation of smooth muscle alpha-actin expression in vivo is dependent on CArG elements within the 5' and first intron promoter regions. Circ Res, 84, 852–861.

15.

Mack

C.P.

, Somlyo

A.V.

, Hautmann

, Somlyo

A.P.

, and Owens

G.K.

(2001). Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization. J Biol Chem, 276, 341–347.

16.

Mandegar

, Fung

Y.C.

, Huang

, Remillard

C.V.

, Rubin

L.J.

, et al. (2004). Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension. Microvasc Res, 68, 75–103.

17.

Morrell

N.W.

, Adnot

, Archer

S.L.

, Dupuis

, Jones

P.L.

, et al. (2009). Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol, 54, S20–S31.

18.

Owens

G.K.

, Kumar

M.S.

, and Wamhoff

B.R.

(2004). Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev, 84, 767–801.

19.

Owens

G.K.

, and Wise

(1997). Regulation of differentiation/maturation in vascular smooth muscle cells by hormones and growth factors. Agents Actions Suppl, 48, 3–24.

20.

Rensen

S.S.

, Doevendans

P.A.

, and van Eys

G.J.

(2007). Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth Heart J, 15, 100–108.

21.

Rubin

L.J.

(1993). Primary pulmonary hypertension. Chest, 104, 236–250.

22.

Schermuly

R.T.

, Ghofrani

H.A.

, Wilkins

M.R.

, and Grimminger

(2011). Mechanisms of disease: pulmonary arterial hypertension. Nat Rev Cardiol, 8, 443–455.

23.

Simonneau

, Robbins

I.M.

, Beghetti

, Channick

R.N.

, Delcroix

, et al. (2009). Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol, 54, S43–S54.

24.

Stokoe

, Stephens

L.R.

, Copeland

, Gaffney

P.R.

, Reese

C.B.

, et al. (1997). Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science, 277, 567–570.

25.

Tang

D.D.

, and Anfinogenova

(2008). Physiologic properties and regulation of the actin cytoskeleton in vascular smooth muscle. J Cardiovasc Pharmacol Ther, 13, 130–140.

26.

Tapon

, and Hall

(1997). Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Curr Opin Cell Biol, 9, 86–92.

27.

Vanhaesebroeck

, Leevers

S.J.

, Ahmadi

, Timms

, Katso

, et al. (2001). Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem, 70, 535–602.

28.

Vanhaesebroeck

, Stephens

, and Hawkins

(2012). PI3K signalling: the path to discovery and understanding. Nat Rev Mol Cell Biol, 13, 195–203.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.14 MB

Role of the PI3K/AKT Pathway in Modulating Cytoskeleton Rearrangements and Phenotype Switching in Rat Pulmonary Arterial Vascular Smooth Muscle Cells

Abstract

Get full access to this article

References

Supplementary Material